{"id":8038,"date":"2026-03-25T08:44:08","date_gmt":"2026-03-25T08:44:08","guid":{"rendered":"https:\/\/www.viamedsalud.com\/ivoqa\/?p=8038"},"modified":"2026-03-25T08:44:15","modified_gmt":"2026-03-25T08:44:15","slug":"timely-access-to-expert-and-multidisciplinary-care-psogi-2025","status":"publish","type":"post","link":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/news\/timely-access-to-expert-and-multidisciplinary-care-psogi-2025\/","title":{"rendered":"Timely access to expert and multidisciplinary care (PSOGI 2025)"},"content":{"rendered":"

In the treatment of peritoneal malignancies, “where”<\/strong> you are treated is just as important as “when.”<\/strong> The PSOGI 2025 Manifesto highlights that many patients receive outdated care because they lack access to specialized teams. At Viamed, through IVOQA<\/strong>, we guarantee cutting-edge care where the patient and their family are the focus of an elite multidisciplinary team.<\/p>\n

 <\/p>\n

Why is a specialized peritoneal center vital?<\/strong><\/h2>\n

Peritoneal surface diseases are complex and cannot be treated in isolation. They require coordinated multidisciplinary management that combines highly complex oncological surgery, medical oncology, expert radiology, and specialized intensive care.<\/p>\n

 <\/p>\n

Current Challenges: Barriers to Healing<\/strong><\/h2>\n

The manifesto identifies the obstacles that prevent patients from reaching experts in time:<\/p>\n

    \n
  • Outdated Treatments:<\/strong> Many patients are treated in centers lacking specific expertise, missing the opportunity for curative-intent techniques such as CRS-HIPEC<\/strong>.<\/li>\n
  • Lack of Personalization:<\/strong> Medical decisions often depend on locally available resources rather than what the patient truly needs.<\/li>\n
  • Bureaucracy and Barriers:<\/strong> Administrative and insurance hurdles often delay referrals to experts\u2014time that the patient simply does not have.<\/li>\n
  • Vague Criteria:<\/strong> It is not always clear what defines a “specialized center,” creating confusion for families.<\/li>\n<\/ul>\n

     <\/p>\n

    How IVOQA Transforms PSOGI 2025 Guidelines into Real Results<\/strong><\/h2>\n

    At IVOQA<\/strong> (Viamed Institute of Advanced Surgical Oncology), led by Dr. Delia Cort\u00e9s Guiral<\/strong>, we have broken down these barriers to offer what the future of oncology demands:<\/p>\n

      \n
    • A Real Multidisciplinary Committee:<\/strong> Every case is analyzed by experts in surgery, oncology, nutrition, internal medicine, etc. There are no unilateral decisions; only personalized plans.<\/li>\n
    • Unrestricted Technology:<\/strong> We offer immediate access to the most advanced techniques\u2014from radical cytoreduction to innovative therapies like PIPAC<\/strong>\u2014ensuring the patient’s location is never an impediment.<\/li>\n
    • International Collaboration:<\/strong> We are integrated into international scientific networks (such as ESPSO<\/strong>), ensuring our protocols follow the latest global scientific evidence.<\/li>\n<\/ul>\n

      Access to medical expertise should not be a privilege, but a right. At IVOQA and Viamed, we work every day to ensure that bureaucracy does not limit potentially life-saving treatments.<\/p>\n

      Do you need an expert team to evaluate your case personally?<\/strong> [Request your appointment with the IVOQA multidisciplinary team] and regain control of your treatment with the support of Dr. Delia Cort\u00e9s Guiral.<\/p>\n

       <\/p>\n

      \n

      Frequently Asked Questions<\/h2>\n
      \n
      What is a multidisciplinary team in peritoneal oncology?<\/div>\n
      It is a group of specialists (surgeons, oncologists, radiologists, pathologists) who meet to design a unique strategy for each patient, ensuring all medical and human needs are met.<\/div>\n<\/div>\n
      \n
      Can I request a referral to IVOQA even if I don\u2019t live in Madrid?<\/div>\n
      Yes. At Viamed, we facilitate the intake of patients from all over Spain, removing administrative barriers so that access to expert care is fast and fair, as demanded by the manifesto.<\/div>\n<\/div>\n
      \n
      What is CRS-HIPEC treatment?<\/div>\n
      It is the combination of Cytoreductive Surgery (to remove the visible tumor) and Hyperthermic Intraperitoneal Chemotherapy (to eliminate microscopic cells). It is the gold standard in centers of excellence.<\/div>\n<\/div>\n
      The information in this section is of a general nature and does not substitute individual medical assessment.<\/div>\n<\/div>\n